Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × treosulfan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 10 Leukemia, Myeloid, Acute 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Biphenotypic, Acute 2 Leukemia 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Shwachman-Diamond Syndrome 1 Sarcoma, Ewing 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Prolymphocytic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hemoglobinuria, Paroxysmal 1 Graft vs Host Disease 1

Interventions

Cyclophosphamide 133 Dexamethasone 108 Rituximab 71 fludarabine 65 Lenalidomide 60 Cytarabine 59 Gemcitabine 54 fludarabine phosphate 49 Bortezomib 48 pembrolizumab 46 venetoclax 45 Etoposide 44 Paclitaxel 43 Carboplatin 42 Cisplatin 41 pomalidomide 39 Peripheral Blood Stem Cell Transplantation 38 Filgrastim 37 Radiotherapy 35 Bevacizumab 33 Melphalan 31 Busulfan 31 Calcium Dobesilate 29 carfilzomib 28 Cyclosporine 28 Methotrexate 27 Azacitidine 26 Nivolumab 25 Mycophenolic Acid 25 Temozolomide 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01010243 2012-05-30

MM03

University of Regensburg

Phase 1/2 Unknown

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡